Literature DB >> 24439750

Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?

Léon Maggiori1, Frédéric Bretagnol1, Muhammad I Aslam2, Nathalie Guedj3, Magaly Zappa4, Marianne Ferron1, Yves Panis5.   

Abstract

BACKGROUND: A pathologic complete response (pCR) can be observed in up to 25% of patients after preoperative chemoradiotherapy for rectal cancer and is associated with an improved long-term prognosis. However, few data are available regarding the effect of pCR on postoperative morbidity. This study aimed to assess the impact of the pCR on postoperative outcomes after laparoscopic total mesorectal excision (TME).
METHODS: A prospectively maintained database (2006-2011) was reviewed for all consecutive patients (n = 143) undergoing laparoscopic TME for mid or low rectal cancer after neoadjuvant chemoradiotherapy. Postoperative data were compared for pCR-group and non-pCR-group. A pCR was defined as the absence of gross and microscopic tumor in the specimen, irrespective of the nodal status (ypT0).
RESULTS: Thirty-three patients (23%) had a pCR. Median operating time was greatly shorter in the pCR-group (230 minutes, 180-360), compared with the non-pCR-group (240 minutes, 130-420, P = .02). Lymph node involvement was noted for 12% of the patients in the pCR-group and 33% of the patients in the non-pCR-group (P = .91). Clavien Dindo grade 3 and 4 complications (6% vs 22%, P = .04), infection related morbidity (47% vs 76%, P = .04), and clinical anastomotic leakage rates (9% vs 29%, P = .02) were lesser in the pCR group compared with the non-pCR group. Mean duration of hospital stay was lesser in the pCR-group (9 vs 12 days, P = .01).
CONCLUSION: This study showed that Clavien Dindo grade 3 and 4 complications, including anastomosis leakage, and infection related complications rates were lesser in patients with pathologic complete response after RCT and laparoscopic TME for rectal cancer.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24439750     DOI: 10.1016/j.surg.2013.10.020

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Colonic prolapse after intersphincteric resection for very low rectal cancer: a report of 12 cases.

Authors:  A Chau; M Frasson; C Debove; L Maggiori; Y Panis
Journal:  Tech Coloproctol       Date:  2016-09-08       Impact factor: 3.781

Review 2.  Is There Any Reason Not to Perform Standard Laparoscopic Total Mesorectal Excision?

Authors:  Zaher Lakkis; Yves Panis
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Risk factors for prolonged postoperative ileus after laparoscopic sphincter-saving total mesorectal excision for rectal cancer: an analysis of 428 consecutive patients.

Authors:  Elisabeth Hain; Léon Maggiori; Cécile Mongin; Justine Prost A la Denise; Yves Panis
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

4.  The REAL (REctal Anastomotic Leak) score for prediction of anastomotic leak after rectal cancer surgery.

Authors:  A Arezzo; M Migliore; P Chiaro; S Arolfo; C Filippini; D Di Cuonzo; R Cirocchi; M Morino
Journal:  Tech Coloproctol       Date:  2019-06-25       Impact factor: 3.781

5.  Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?

Authors:  Martin Svoboda; Vladimír Procházka; Tomáš Grolich; Tomáš Pavlík; Monika Mazalová; Zdeněk Kala
Journal:  J Gastrointest Cancer       Date:  2022-05-07

6.  Pathologic response grade after long-course neoadjuvant chemoradiation does not influence morbidity in locally advanced mid-low rectal cancer resected by laparoscopy.

Authors:  Filippo Landi; Eloy Espín; Victor Rodrigues; Francesc Vallribera; Aleix Martinez; Cecile Charpy; Francesco Brunetti; Daniel Azoulay; Nicola de'Angelis
Journal:  Int J Colorectal Dis       Date:  2016-10-19       Impact factor: 2.571

7.  Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?

Authors:  Clotilde Debove; Nathalie Guedj; Ecoline Tribillon; Léon Maggiori; Magaly Zappa; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2016-03-07       Impact factor: 2.571

8.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; David M Mattson; Emmanuel Gabriel; Steven J Nurkin
Journal:  Ann Surg Oncol       Date:  2015-12-14       Impact factor: 5.344

Review 9.  Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.

Authors:  J Yang; W Wang; Y Luo; S Huang; Z Fu
Journal:  Tech Coloproctol       Date:  2022-01-20       Impact factor: 3.781

Review 10.  Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal cancer: A systematic review and meta-analysis.

Authors:  Aleix Martínez-Pérez; Maria Clotilde Carra; Francesco Brunetti; Nicola de'Angelis
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.